Delivery Order SPE2DE24DA017-SPE2D625F0DRD
- Not listed
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $6,879.70 to Arthrex Inc. for a Fibertak Biceps Implant Set. This fixed-price contract with economic price adjustment mechanism was awarded on July 18, 2025, with an ultimate completion date of August 1, 2025. The order will be performed in Naples, Florida, where Arthrex maintains its headquarters. This delivery order was issued under no set-aside designation, reflecting the contractor's strong competitive...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $2,696.10 fixed-price delivery order with economic price adjustment from the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, for Fibertak biceps implants. This delivery order represents work under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) valued at $471 million, which runs through September 1, 2029, and enables Veterans Affairs medical centers nationwide to procure the...
- The U.S. government agency, the Defense Logistics Agency's Medical Supply Chain, awarded a $5,631.78 fixed-price delivery order with economic price adjustment to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the production and delivery of FIBERTAK BICEPS IMPLANT, a specialized medical device. This delivery order is part of a larger $471,048,172.66 Indefinite Delivery Contract (IDC) held by Arthrex with the Defense Logistics Agency, which...
- Arthrex Inc., a leading minimally invasive orthopedic medical device manufacturer headquartered in Naples, Florida, received a fixed-price delivery order valued at $4,815.79 for a Fibertak Biceps Implant Set from the Defense Logistics Agency's Medical Supply Chain division. The delivery order, awarded on August 4, 2025, with an ultimate completion date of August 7, 2025, represents performance-based fulfillment under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $7,513.30, is for the provision of a FIBERTAK BICEPS IMPLANT SET, a specialized orthopedic medical device. The contract is a fixed-price agreement with economic price adjustment, with a completion date of April 8, 2025. Arthrex Inc. is a for-profit Subchapter S Corporation...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a for-profit Subchapter S Corporation based in Naples, Florida. The contract, valued at $13,986.73, is for the provision of a FIBERTAK BICEPS IMPLANT SET. The contract has a period of performance through April 30, 2025 and utilizes a fixed price with economic price adjustment pricing type. This contract is not set aside for any specific business type. Arthrex Inc. is a global...
- This federal contract award, issued by the Defense Logistics Agency's Medical Supply Chain, is for the procurement of a FIBERTAK BICEPS IMPLANT SET by Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is a Delivery Order with a Ceiling Value of $1,585.82, utilizing a Fixed Price with Economic Price Adjustment pricing type. The contract has an Ultimate Completion Date of January 30, 2025. Arthrex Inc., a for-profit Subchapter S Corporation...
- This is a federal delivery order contract awarded to Arthrex Inc., a for-profit Subchapter S Corporation based in Naples, Florida. The contract, valued at $1,375.94, was awarded by the Defense Logistics Agency's Medical Supply Chain for the procurement of a FIBERTAK BICEPS IMPLANT SET. The contract has a fixed-price with economic price adjustment pricing type and a completion date of April 14, 2025. Arthrex is a global leader in minimally invasive orthopedic medical technologies and holds a...
- This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, by the Defense Logistics Agency's Medical Supply Chain. The contract, valued at $2,666.75, is for the delivery of a FIBERTAK BICEPS IMPLANT SET, a specialized orthopedic medical device. The contract is a Delivery Order with a fixed price with economic price adjustment pricing type and has an ultimate completion date of January 27, 2025. This contract is not set aside for a...
- The U.S. government's Defense Logistics Agency (DLA) awarded a fixed-price delivery order contract worth $12,520.20 to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, for the supply of a FIBERTAK BICEPS IMPLANT. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $471,048,172.66 between Arthrex and the DLA, which allows VA medical centers nationwide to acquire the company's innovative orthopedic technologies through task orders....
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F0DRDDelivery Order
This delivery order, valued at $1,375.94 with a fixed-price contract type featuring economic price adjustment provisions, was awarded on August 5, 2025, to Arthrex Inc. for the supply of a FIBERTAK BICEPS IMPLANT SET. The contract is not set-aside and was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. Performance is scheduled for completion by August 8, 2025, at Arthrex's location in Naples, Florida. The FIBERTAK system represents one of Arthrex's specialized orthopedic surgical solutions, which the company manufactures and supplies to government healthcare systems, particularly the Department of Veterans Affairs and Department of Defense. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and spanning from June 2024 through September 2029. This comprehensive IDC enables VA medical centers nationwide to procure Arthrex's full portfolio of minimally invasive orthopedic technologies, including surgical implants, arthroscopic instruments, and specialized surgical systems. As a global leader in orthopedic medical device manufacturing, Arthrex maintains a strong competitive position in the federal marketplace and has demonstrated its capability to support government healthcare requirements across multiple orthopedic specialties.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/5/25 |